Article Text

Download PDFPDF
Immune complex associated complications in the subacute phase of meningococcal disease: incidence and literature review
  1. C A Goedvolk,
  2. I A von Rosenstiel,
  3. A P Bos
  1. Department of Pediatric Intensive Care, Academic Medical Center, University of Amsterdam, Emma Children’s Hospital/AMC, Amsterdam, Netherlands
  1. Correspondence to:
    Dr A P Bos, Emma Children’s Hospital/AMC, PICU G8ZW, PO Box 22700, 1100 DE Amsterdam, Netherlands;
    a.p.bos{at}amc.uva.nl

Abstract

Aim: To determine the incidence of immune complex associated complications (IAC) after severe meningococcal disease (SMD) in a group of Dutch children admitted to a paediatric intensive care unit (PICU).

Methods: Retrospective chart analysis and follow up of 130 survivors of SMD admitted to PICU. Signs of IAC, inflammatory parameters, and temperature profile were reviewed.

Results: Of 130 children with SMD, 20 (15.3%) showed one or more of the three manifestations of IAC: 18 (13.8%) developed arthritis (effusion, with or without erythema/arthralgia), 11 (8.4%) vasculitis, and five (3.8%) pleuritis. Eighteen of 20 (90%) patients with IAC had a secondary rise in temperature; in patients with no IAC this was 48 of 110 (43.6%). IAC was associated with leucocytosis in 82.3% versus 47.7% in patients without IAC, and with increased CRP in 86.6% versus 47.2% in patients without IAC. Leucocytes on admission were significantly lower in patients who would later develop IAC (mean 8.6 versus 13.8×109/l).

Conclusion: IAC is a common complication of SMD, mainly occurring 4–10 days after systemic disease. IAC presents clinically as arthritis or vasculitis, mostly accompanied by secondary fever and raised inflammatory parameters.

  • meningococcal disease
  • type 3 hypersensitivity
  • reactive arthritis
  • complications
  • CRP, C reactive protein
  • ESR, erythrocyte sedimentation rate
  • IAC, immune complex associated complications
  • PICU, paediatric intensive care unit
  • SMD, severe meningococcal disease

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes